Research Output per year
Personal profile
Bio
Dr. Bejjani is board certified in Infectious Diseases and Internal Medicine. She maintains membership in the Infectious Diseases Society of America and has held academic appointments since 2007. Dr. Bejjani has numerous publications and national/international abstracts and presentations. She currently practices at the Seton Trinity Facility.
Fingerprint Dive into the research topics where Dalia Bejjani is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
rosiglitazone
Medicine & Life Sciences
HIV
Medicine & Life Sciences
Carotid Intima-Media Thickness
Medicine & Life Sciences
Placebos
Medicine & Life Sciences
Reverse Transcriptase Inhibitors
Medicine & Life Sciences
Peroxidase
Medicine & Life Sciences
Thymidine
Medicine & Life Sciences
Peroxisome Proliferator-Activated Receptors
Medicine & Life Sciences
Research Output 2007 2013
- 8 Article
13
Citations
(Scopus)
A case of endocarditis caused by lactococcus garvieae and suggested methods for identification
Navas, M. E., Hall, G. & Bejjani, D., Jun 1 2013, In : Journal of Clinical Microbiology. 51, 6, p. 1990-1992 3 p.Research output: Contribution to journal › Article
Lactococcus
Endocarditis
Fishes
Gram-Positive Cocci
Heart Valves
4
Citations
(Scopus)
Changes in inflammation, oxidative stress, mitochondrial DNA content after rosiglitazone in HIV lipoatrophy
Tungsiripat, M., Bejjani, D., Rizk, N., Hu, B., Ross, A. C., Walker, U. A., Lebrecht, D., Milne, G., Storer, N. & McComsey, G. A., Oct 1 2012, In : Journal of AIDS and Clinical Research. 3, 8Research output: Contribution to journal › Article
rosiglitazone
Peroxisome Proliferator-Activated Receptors
Mitochondrial DNA
Oxidative Stress
Tumor Necrosis Factor Receptors
8
Citations
(Scopus)
Carotid intima media thickness, inflammatory markers, and endothelial activation markers in HIV patients with lipoatrophy increased at 48 weeks regardless of use of rosiglitazone or placebo
Tungsiripat, M., Bejjani, D., Rizk, N., Dogra, V., O'Riordan, M. A., Ross, A. C., Hileman, C., Storer, N., Harrill, D. & McComsey, G. A., Mar 1 2011, In : AIDS Research and Human Retroviruses. 27, 3, p. 295-302 8 p.Research output: Contribution to journal › Article
rosiglitazone
Carotid Intima-Media Thickness
Placebos
HIV
Vascular Cell Adhesion Molecule-1
27
Citations
(Scopus)
Rosiglitazone improves lipoatrophy in patients receiving thymidine-sparing regimens
Tungsiripat, M., Bejjani, D., Rizk, N., O'Riordan, M. A., Ross, A. C., Hileman, C., Storer, N., Harrill, D. & McComsey, G. A., Jun 1 2010, In : AIDS. 24, 9, p. 1291-1298 8 p.Research output: Contribution to journal › Article
rosiglitazone
Reverse Transcriptase Inhibitors
Thymidine
Placebos
Peroxisome Proliferator-Activated Receptors
170
Citations
(Scopus)
Relationship between Inflammatory Markers, Endothelial Activation Markers, and Carotid Intima-Media Thickness in HIV-infected Patients Receiving Antiretroviral Therapy
Ross, A. C., Rizk, N., O'Riordan, M. A., Dogra, V., Bejjani, D., Storer, N., Harrill, D., Tungsiripat, M., Adell, J. & McComsey, G. A., Oct 1 2009, In : Clinical Infectious Diseases. 49, 7, p. 1119-1127 9 p.Research output: Contribution to journal › Article
Carotid Intima-Media Thickness
HIV
Internal Carotid Artery
Vascular Cell Adhesion Molecule-1
Therapeutics